NCT05564377 2026-03-18
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Astellas Pharma Inc
Coherus Oncology, Inc.
I-Mab Biopharma US Limited
AstraZeneca
UNICANCER
Taiho Pharmaceutical Co., Ltd.
Ruijin Hospital